PRTODAY / NewswireToday Free press release distribution service network

Written by / Agency / Source: RespiTrend, Inc.

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

RespiTrend, Inc. Introduces Noninvasive Medical Monitoring Technologies for Propofol and Glucose - New noninvasive medical monitoring devices for blood propofol and blood glucose monitoring under development - RespiTrend.com
RespiTrend, Inc. Introduces Noninvasive Medical Monitoring Technologies for Propofol and Glucose

 

NewswireToday - /newswire/ - Gainesville, FL, United States, 2016/01/26 - New noninvasive medical monitoring devices for blood propofol and blood glucose monitoring under development - RespiTrend.com.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Medical Services/Equipment Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

RespiTrend, Inc., announces it has secured exclusive patent and related rights for two technologies which have the potential to make a major impact on healthcare:

• PROPOTREND™, a non-invasive monitor for the most widely used intravenous anesthetic agent, propofol, which measures changes in the free concentration of propofol in the blood by measuring changes in the propofol concentration in exhaled breath. At present, there is no real-time way for medical practitioners to know how much propofol is reaching the brain. PROPOTREND™ measures the same fraction of propofol that crosses the blood-brain barrier by measuring propofol that crosses the alveolar lining to enter the exhaled breath, taking the guess-work out of propofol induced sedation.

• GLUCOTREND™, a non-invasive blood glucose monitor, which measures changes in the concentration of glucose in the exhaled breath and correlates those changes with changes in blood glucose concentration. According to the International Diabetes Foundation (see diabetesatlas.org),“One in two adults with diabetes is undiagnosed” and is therefore unaware that they are at risk. This technology has the potential to significantly alter that situation by making it more convenient and less painful to determine one’s at-risk status.

These patented technologies (GLUCOTREND™ see US Patent No. 7,914, 460; PROPOTREND™, see US Patent Nos. 7,104, 963; 6,981, 947; 8,211, 035, and EPO Patent Nos. EO1610681 and EP2055233) are based on inventions devised by teams of researchers at the University of Florida, including Dr. Richard J. Melker, Dr. Donn M. Dennis, and several of their colleagues. The patents were exclusively licensed by the University of Florida Research Foundation, Inc. to Xhale, Inc., and are now exclusively licensed to RespiTrend, Inc.

“We are committed to taking the PROPOTREND™ and GLUCOTREND™ technologies forward for further development, regulatory review and subsequent market introduction”, said Gerard Bencen, Esq., CEO, President and Chairman of the Board of RespiTrend, Inc. “While Xhale initiated development of these technologies, it has focused its work on its line of nasal alar pulse oximetry sensors and a novel medication adherence monitoring technology for the pharmaceutical industry. As Xhale’s long-time former IP counsel, I am grateful for the opportunity to lead this next phase of technology development for these critically important medical devices,” said Mr. Bencen.

RespiTrend, Inc., is seeking sufficient investment to permit advancement through regulatory approval and market introduction of these technologies. “Commercial success in this effort will provide life-changing, paradigm-shifting, non-invasive medical devices to the medical community and general public,” concluded Mr. Bencen.

About RespiTrend, Inc. (“RTI”)

RespiTrend, Inc. (respitrend.com) is a medical technology company which is raising capital to advance commercialization of two technology platforms, PROPOTREND™ and GLUCOTREND™ for the healthcare industry.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Medical Services/Equipment Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: RespiTrend, Inc.

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick Newswire Today Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 
 
  Your Banner Ad showing on ALL
Medical Services/Equipment articles,
CATCH Visitors via Your Competitors Announcements!


RespiTrend, Inc. Introduces Noninvasive Medical Monitoring Technologies for Propofol and Glucose

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
 
  Is this your article?
Activate ALL web links and social stream by Upgrading to Press Release PREMIUM Plan Now!

|
Publisher Contact: Gerard Bencen - RespiTrend.com 
407-529-5888 gbencen[.]respitrend.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any RespiTrend, Inc. securities in any jurisdiction including any other companies listed or named in this release.

Medical Services/Equipment via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From RespiTrend, Inc. / Company Profile


Read Medical Services/Equipment Most Recent Related Newswires:

Frost & Sullivan Recognizes Ventec Life Systems for New Product Innovation - Game-changing, Modular Respiratory System, VOCSN
BD Expands Genomics Portfolio with New Single Cell Platform for RNA Expression Analysis
GE Healthcare Advances the Delivery of Cell Therapies with New Thawing Technology
Ansell Limited Announces the Closing of the Sale of its Sexual Wellness Business
PQ Bypass Earns Frost & Sullivan’s European Technology Innovation Award for its Proprietary DETOUR System for Percutaneous Bypass
Curaçao EMS Uses ZOLL Autopulse to Save Tourist in Sudden Cardiac Arrest
ZOLL to Showcase Expanded Portfolio of AEDs at Caravan Salon 2017
MDxHealth Announces Service Agreement with Kaiser Southern California Permanente Medical Group
Frost & Sullivan Lauds CytoSorbents for Leading the Critical Care Immunotherapy Segment with its Novel Blood Purification Solution, CytoSorb®
MVZ Dr. Stein & Kollegen First German Medical Laboratory to Offer the SelectMDx for Prostate Cancer Test
Datalogic Announces New Healthcare Memor X3 HC Mobile Computer
Neuronix Ltd Announces the First Group of Mild to Moderate Alzheimer Patients to be Successfully Treated by The NeuroAD™ Therapy System
SelectMDx to be Distributed Across Middle East by IPS Genomix
GE Healthcare Partners with Oritain to Introduce Independent Test to Confirm Country of Origin of Fetal Bovine Serum
Saebo, Inc. Awarded Patent for Low-Profile Stroke Recovery Glove

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  BizJobs.com

Visit  RightITnow Ltd





 
  ©2017 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)